| 证券代码 | APOPW.O |
| 证券名称 | Cellect Biotechnology Ltd Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2016-07-29 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Quoin Pharmaceuticals, Ltd. |
| 注册地址 | 以色列 |
| 办公地址 | 42127 Pleasant Forest Court Ashburn , Virginia, USA |
| 成立日期 | 1986-08-04 |
| 董事会主席 | - |
| 公司属地 | Israel 以色列 |
| 公司网址 | www.quoinpharma.com |
| 电话 | +1 (703) 980-4182 |
| 传真 | - |
| 公司简介 | Quoin Pharmaceuticals, Ltd. (QNRX) is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. The company is committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others. |